News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
599,611 Results
Type
Article (46017)
Company Profile (582)
Press Release (553012)
Section
Business (163156)
Career Advice (2378)
Deals (30984)
Drug Delivery (106)
Drug Development (71511)
Employer Resources (136)
FDA (16974)
Job Trends (13471)
News (292570)
Policy (33251)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (10)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (4)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
Academia (2635)
Academic (1)
Accelerated approval (2)
Adcomms (22)
Allergies (76)
Alliances (44785)
ALS (78)
Alzheimer's disease (1261)
Antibody-drug conjugate (ADC) (98)
Approvals (16953)
Artificial intelligence (233)
Autoimmune disease (12)
Automation (14)
Bankruptcy (300)
Best Places to Work (11201)
BIOSECURE Act (20)
Biosimilars (102)
Biotechnology (403)
Bladder cancer (52)
Brain cancer (24)
Breast cancer (230)
Cancer (1733)
Cardiovascular disease (132)
Career advice (1988)
Career pathing (26)
CAR-T (131)
Cell therapy (368)
Cervical cancer (14)
Clinical research (57882)
Collaboration (665)
Compensation (291)
Complete response letters (20)
COVID-19 (2682)
CRISPR (35)
C-suite (159)
Cystic fibrosis (91)
Data (1681)
Decentralized trials (2)
Denatured (5)
Depression (38)
Diabetes (224)
Diagnostics (6196)
Digital health (19)
Diversity (5)
Diversity, equity & inclusion (34)
Drug discovery (110)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (67)
Earnings (64194)
Editorial (34)
Employer branding (17)
Employer resources (124)
Events (79273)
Executive appointments (511)
FDA (18001)
Featured Employer (46)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (609)
Gene editing (88)
Generative AI (26)
Gene therapy (253)
GLP-1 (630)
Government (4628)
Grass and pollen (3)
Guidances (46)
Healthcare (17631)
Huntington's disease (16)
IgA nephropathy (20)
Immunology and inflammation (75)
Indications (22)
Infectious disease (2809)
Inflammatory bowel disease (127)
Inflation Reduction Act (8)
Influenza (40)
Intellectual property (76)
Interviews (444)
IPO (15080)
IRA (40)
Job creations (2794)
Job search strategy (1662)
Kidney cancer (8)
Labor market (23)
Layoffs (375)
Leadership (17)
Legal (7597)
Liver cancer (70)
Lung cancer (246)
Lymphoma (114)
Machine learning (2)
Management (47)
Manufacturing (257)
MASH (49)
Medical device (13147)
Medtech (13152)
Mergers & acquisitions (16337)
Metabolic disorders (541)
Multiple sclerosis (60)
NASH (10)
Neurodegenerative disease (67)
Neuropsychiatric disorders (17)
Neuroscience (1671)
NextGen: Class of 2025 (6400)
Non-profit (4278)
Northern California (1964)
Now hiring (9)
Obesity (284)
Opinion (211)
Ovarian cancer (57)
Pain (76)
Pancreatic cancer (66)
Parkinson's disease (109)
Partnered (16)
Patents (191)
Patient recruitment (83)
Peanut (48)
People (43606)
Pharmaceutical (117)
Pharmacy benefit managers (20)
Phase I (17365)
Phase II (25119)
Phase III (19981)
Pipeline (784)
Podcasts (26)
Policy (108)
Postmarket research (2502)
Preclinical (7097)
Press Release (70)
Prostate cancer (83)
Psychedelics (31)
Radiopharmaceuticals (235)
Rare diseases (326)
Real estate (4944)
Recruiting (57)
Regulatory (22933)
Reports (33)
Research institute (2339)
Resumes & cover letters (396)
Rett syndrome (3)
RNA editing (2)
RSV (44)
Schizophrenia (55)
Series A (106)
Series B (63)
Service/supplier (23)
Sickle cell disease (47)
Southern California (1785)
Special edition (15)
Sponsored (31)
Startups (3182)
State (2)
Stomach cancer (15)
Supply chain (56)
The Weekly (21)
United States (18244)
Vaccines (673)
Venture capitalists (24)
Webinars (7)
Weight loss (194)
Women's health (23)
Worklife (14)
Date
Today (81)
Last 7 days (564)
Last 30 days (2760)
Last 365 days (32215)
2025 (5839)
2024 (33122)
2023 (37236)
2022 (48158)
2021 (52133)
2020 (51147)
2019 (43967)
2018 (33758)
2017 (30915)
2016 (29368)
2015 (33630)
2014 (25224)
2013 (20680)
2012 (22442)
2011 (22733)
2010 (20242)
Location
Africa (797)
Alabama (43)
Alaska (7)
Arizona (140)
Arkansas (12)
Asia (36808)
Australia (6506)
California (4704)
Canada (1601)
China (390)
Colorado (221)
Connecticut (244)
Delaware (114)
Europe (82638)
Florida (718)
Georgia (176)
Hawaii (1)
Idaho (50)
Illinois (442)
India (22)
Indiana (259)
Iowa (8)
Japan (124)
Kansas (90)
Kentucky (16)
Louisiana (9)
Maine (59)
Maryland (762)
Massachusetts (3518)
Michigan (194)
Minnesota (309)
Mississippi (2)
Missouri (77)
Montana (25)
Nebraska (20)
Nevada (46)
New Hampshire (64)
New Jersey (1432)
New Mexico (27)
New York (1369)
North Carolina (856)
North Dakota (7)
Northern California (1964)
Ohio (171)
Oklahoma (9)
Oregon (35)
Pennsylvania (990)
Puerto Rico (4)
Rhode Island (24)
South America (1066)
South Carolina (14)
South Dakota (1)
Southern California (1785)
Tennessee (80)
Texas (704)
Utah (144)
Virginia (129)
Washington D.C. (55)
Washington State (458)
West Virginia (3)
Wisconsin (52)
599,611 Results for "cibus us llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts
March 5, 2025
·
6 min read
Press Releases
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
January 14, 2025
·
7 min read
Deals
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
Calyxt, Inc., a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, announced that the registration statement on Form S-4, initially filed with the U.S. Securities and Exchange Commission by Calyxt on February 14, 2023, and amended on April 14, 2023, has been declared effective by the SEC.
April 18, 2023
·
10 min read
Business
ValGenesis Announces Trinity Bridge Professional Services LLC as Service Partner for U.S.
ValGenesis Inc. and Trinity Bridge Professional Services LLC have partnered to extend a suite of digital validation solutions from ValGenesis to help companies in the U.S. respond rapidly to increasingly dynamic environments.
January 30, 2024
·
3 min read
Press Releases
TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
November 11, 2024
·
8 min read
Press Releases
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
February 24, 2025
·
6 min read
Press Releases
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
March 6, 2025
·
5 min read
Press Releases
Catheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLC
February 4, 2025
·
6 min read
Press Releases
ITF Therapeutics LLC Announces Multiple Data Presentations at 2025 MDA Clinical and Scientific Conference
February 21, 2025
·
7 min read
Policy
Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
Calyxt, Inc., a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, announced that Calyxt has filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission on February 14, 2023.
February 15, 2023
·
10 min read
1 of 59,962
Next
